68Ga-Exendin-4 PET/CT鉴别胰岛素瘤与副脾
一例55岁女性内源性高胰岛素性低血糖患者,临床诊断为胰岛素瘤。增强MRI显示胰尾低信号病灶但强化模式不支持胰岛素瘤,68Ga-DOTATATE PET/CT显示该结节与邻近脾脏放射性相似,不能排除副脾。68Ga-exendin-4 PET/CT显示结节强烈摄取而脾脏无明显摄取,从而排除副脾、明确胰岛素瘤并得以行根治性手术。
要点
- 68Ga-exendin-4 PET/CT可用于鉴别胰岛素瘤与副脾。
- 当68Ga-DOTATATE PET/CT病灶摄取与脾脏相似时,需考虑副脾可能。
- 68Ga-exendin-4 PET/CT脾脏无明显摄取有助于排除副脾。
核心结论
- 68Ga-exendin-4 PET/CT可鉴别胰岛素瘤与副脾,使患者得以行根治性手术。
研究设计与样本
- 个案报道:一例55岁女性内源性高胰岛素性低血糖患者,临床诊断为胰岛素瘤。
主要发现
- 增强MRI显示胰尾低信号病灶,强化模式不支持胰岛素瘤诊断。
- 68Ga-DOTATATE PET/CT显示该结节放射性强烈,与邻近脾脏相似,不能排除副脾。
- 68Ga-exendin-4 PET/CT显示该结节强烈摄取,而脾脏无明显摄取,排除副脾并明确胰岛素瘤。
临床怎么用
- 对MRI和68Ga-DOTATATE PET/CT结果不确定的胰岛素瘤疑似病例,可考虑68Ga-exendin-4 PET/CT鉴别副脾。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 55-year-old woman with endogenous hyperinsulinemia hypoglycemia was clinically diagnosed with insulinoma. Contrast-enhanced MRI revealed an inconclusive hypointense lesion in the pancreatic tail, and the enhancement pattern does not support the diagnosis of insulinoma. 68Ga-DOTATATE PET/CT showed intense radioactivity in this nodule, similar to the radioactivity of the adjacent spleen. Therefore, the diagnosis of accessory spleen cannot be excluded. Follow-up with 68Ga-exendin-4 PET/CT also showed intense uptake in this nodule, but no significant uptake in the spleen was observed at this time. Therefore, the insulinoma was unmasked from the spleen, excluding the diagnosis of accessory spleen, and allowing curative surgery.
引用
- Pang Y, Meng T, Shang Q, et al. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings. Clin Nucl Med. 2022. PMID: 34507334. doi:10.1097/RLU.0000000000003895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。